000 | 01923 a2200517 4500 | ||
---|---|---|---|
005 | 20250515112303.0 | ||
264 | 0 | _c20080617 | |
008 | 200806s 0 0 eng d | ||
022 | _a1097-6825 | ||
024 | 7 |
_a10.1016/j.jaci.2007.12.1175 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSel, Serdar | |
245 | 0 | 0 |
_aEffective prevention and therapy of experimental allergic asthma using a GATA-3-specific DNAzyme. _h[electronic resource] |
260 |
_bThe Journal of allergy and clinical immunology _cApr 2008 |
||
300 |
_a910-916.e5 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAcute Disease |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
650 | 0 | 4 |
_aAsthma _xdrug therapy |
650 | 0 | 4 |
_aBronchial Hyperreactivity _xenzymology |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aChronic Disease |
650 | 0 | 4 |
_aDNA, Antisense _xpharmacology |
650 | 0 | 4 |
_aDNA, Catalytic _xtherapeutic use |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aEnzyme Activation _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGATA3 Transcription Factor _xantagonists & inhibitors |
650 | 0 | 4 |
_aInflammation Mediators _xantagonists & inhibitors |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 |
_aOvalbumin _xtoxicity |
650 | 0 | 4 |
_aRNA, Messenger _xantagonists & inhibitors |
650 | 0 | 4 |
_aRNA, Small Interfering _xpharmacology |
650 | 0 | 4 |
_aSubstrate Specificity _xgenetics |
700 | 1 | _aWegmann, Michael | |
700 | 1 | _aDicke, Tanja | |
700 | 1 | _aSel, Sarper | |
700 | 1 | _aHenke, Wolfgang | |
700 | 1 | _aYildirim, Ali O | |
700 | 1 | _aRenz, Harald | |
700 | 1 | _aGarn, Holger | |
773 | 0 |
_tThe Journal of allergy and clinical immunology _gvol. 121 _gno. 4 _gp. 910-916.e5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jaci.2007.12.1175 _zAvailable from publisher's website |
999 |
_c17827885 _d17827885 |